Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) Operating Expenses (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Operating Expenses data on record, last reported at $18.5 million in Q4 2025.

  • For Q4 2025, Operating Expenses fell 8.61% year-over-year to $18.5 million; the TTM value through Dec 2025 reached $77.3 million, up 37.39%, while the annual FY2025 figure was $77.3 million, 37.39% up from the prior year.
  • Operating Expenses reached $18.5 million in Q4 2025 per PLSE's latest filing, down from $20.5 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $20.5 million in Q3 2025 and bottomed at $8.7 million in Q4 2022.
  • Average Operating Expenses over 5 years is $15.0 million, with a median of $14.8 million recorded in 2021.
  • Peak YoY movement for Operating Expenses: crashed 46.25% in 2022, then soared 72.91% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $16.3 million in 2021, then plummeted by 46.25% to $8.7 million in 2022, then skyrocketed by 43.46% to $12.5 million in 2023, then surged by 61.66% to $20.3 million in 2024, then dropped by 8.61% to $18.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $18.5 million in Q4 2025, $20.5 million in Q3 2025, and $20.3 million in Q2 2025.